Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Everall, I. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Everall, I. P.
Related Collections
Right arrow Gene expression studies
Right arrow HIV
Right arrow Depression
Right arrow HIV dementia
NEUROLOGY 2006;67:1867-1869
© 2006 American Academy of Neurology


Brief Communications

Diminished somatostatin gene expression in individuals with HIV and major depressive disorder

I. P. Everall, FRCPsych, FRCPath, PhD, S. Salaria, BSc, MSc, J. H. Atkinson, MD, C. Young, PhD, J. Corbeil, PhD, I. Grant, MD, E. Masliah, MD and from the HNRC*

From the Departments of Psychiatry (I.P.E., J.H.A., I.G.) and Neuroscience (E.M.), University of California, San Diego (S.S., C.Y.); and Department of Medical Genomics (J.C.), Laval University, Quebec, Canada.

Address correspondence and reprint requests to Dr Everall, Department of Psychiatry, 9500 Gilman Dr., La Jolla CA 92093-0603; e-mail: ieverall{at}ucsd.edu

In analyzing the expression of 15 candidate genes for HIV encephalitis (HIVE) by the presence or absence of major depressive disorder (MDD), we noted significant reductions in the expression of four cytoskeletal genes and somatostatin. Whereas disruption of cytoskeletal genes has been noted in HIVE, dysregulation of somatostatin has not, indicating that dysregulation of somatostatin is part of the molecular pathologic process of MDD in the setting of HIV.


*See the appendix for a complete list of Group members.

J.C. is a holder of a Canadian Research Chair and acknowledges the support of the Center for AIDS Research Genomics Core Laboratory, University of California, San Diego. The HIV Neurobehavioral Research Center (HNRC) is supported by center award MH 62512 from NIMH.

Disclosure: The authors report no conflicts of interest.

Received April 1, 2005. Accepted in final form July 24, 2006.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.